324 related articles for article (PubMed ID: 27823573)
21. Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling.
Szepanowski F; Derksen A; Steiner I; Meyer Zu Hörste G; Daldrup T; Hartung HP; Kieseier BC
J Neuroinflammation; 2016 Jun; 13(1):143. PubMed ID: 27283020
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
Cohen JA; Chun J
Ann Neurol; 2011 May; 69(5):759-77. PubMed ID: 21520239
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Singh SK; Spiegel S
Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
[TBL] [Abstract][Full Text] [Related]
24. The S1P-S1PR Axis in Neurological Disorders-Insights into Current and Future Therapeutic Perspectives.
Lucaciu A; Brunkhorst R; Pfeilschifter JM; Pfeilschifter W; Subburayalu J
Cells; 2020 Jun; 9(6):. PubMed ID: 32580348
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.
Tiper IV; East JE; Subrahmanyam PB; Webb TJ
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354294
[TBL] [Abstract][Full Text] [Related]
26. Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
Ghasemi R; Dargahi L; Ahmadiani A
Pharmacol Res; 2016 Feb; 104():156-64. PubMed ID: 26772814
[TBL] [Abstract][Full Text] [Related]
27. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
[TBL] [Abstract][Full Text] [Related]
28. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.
Pérez-Jeldres T; Alvarez-Lobos M; Rivera-Nieves J
Drugs; 2021 Jun; 81(9):985-1002. PubMed ID: 33983615
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors.
Delgado A; Martínez-Cartro M
Curr Med Chem; 2016; 23(3):242-64. PubMed ID: 26639095
[TBL] [Abstract][Full Text] [Related]
30. The role of sphingosine 1-phosphate metabolism in brain health and disease.
van Echten-Deckert G
Pharmacol Ther; 2023 Apr; 244():108381. PubMed ID: 36907249
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures.
Brunati AM; Tibaldi E; Carraro A; Gringeri E; D'Amico F; Toninello A; Massimino ML; Pagano MA; Nalesso G; Cillo U
Biochim Biophys Acta; 2008 Mar; 1783(3):347-59. PubMed ID: 18157950
[TBL] [Abstract][Full Text] [Related]
32. The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.
Martín-Montañez E; Pavia J; Valverde N; Boraldi F; Lara E; Oliver B; Hurtado-Guerrero I; Fernandez O; Garcia-Fernandez M
Free Radic Biol Med; 2019 Jun; 137():116-130. PubMed ID: 31035004
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate (S1P) signaling regulates the production of intestinal IgA and its potential role in the pathogenesis of canine inflammatory bowel disease.
Nakazawa M; Maeda S; Yokoyama N; Nakagawa T; Yonezawa T; Ohno K; Matsuki N
J Vet Med Sci; 2019 Sep; 81(9):1249-1258. PubMed ID: 31341112
[TBL] [Abstract][Full Text] [Related]
34. Modulation of sphingosine-1-phosphate in inflammatory bowel disease.
Peyrin-Biroulet L; Christopher R; Behan D; Lassen C
Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838
[TBL] [Abstract][Full Text] [Related]
35. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
Danese S; Furfaro F; Vetrano S
J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
[TBL] [Abstract][Full Text] [Related]
36. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.
Hemdan NY; Weigel C; Reimann CM; Gräler MH
Eur J Immunol; 2016 Dec; 46(12):2767-2777. PubMed ID: 27683081
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.
Aoki M; Aoki H; Ramanathan R; Hait NC; Takabe K
Mediators Inflamm; 2016; 2016():8606878. PubMed ID: 26966342
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1 phosphate and central nervous system.
Martin R; Sospedra M
Curr Top Microbiol Immunol; 2014; 378():149-70. PubMed ID: 24728597
[TBL] [Abstract][Full Text] [Related]
39. Targeting sphingosine-1-phosphate signaling for cancer therapy.
Xie Z; Liu H; Geng M
Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
[TBL] [Abstract][Full Text] [Related]
40. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
Chua XY; Ho LTY; Xiang P; Chew WS; Lam BWS; Chen CP; Ong WY; Lai MKP; Herr DR
Neuromolecular Med; 2021 Mar; 23(1):47-67. PubMed ID: 33180310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
